Cubist Systematic Strategies, LLC Pacira Bio Sciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 554,387 shares of PCRX stock, worth $10.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

554,387

Holding current value

$10.8 Million

% of portfolio

0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $6.49 Million - $15.8 Million	554,387 New	554,387 $8.35 Million
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $2.67 Million - $3.42 Million	96,337 Added 253.89%	134,282 $3.92 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $2.48 Million - $3.23 Million	-94,053 Reduced 71.25%	37,945 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $3.59 Million - $4.69 Million	116,889 Added 773.64%	131,998 $4.05 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $2.19 Million - $2.87 Million	-60,505 Reduced 80.02%	15,109 $605,000
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $3.87 Million - $4.73 Million	-109,059 Reduced 59.06%	75,614 $3.09 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $6.05 Million - $9.1 Million	158,481 Added 605.07%	184,673 $7.13 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $831,573 - $955,725	16,229 Added 162.89%	26,192 $1.39 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $46,752 - $74,129	-908 Reduced 8.35%	9,963 $581,000
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $3.11 Million - $3.96 Million	-51,798 Reduced 82.65%	10,871 $830,000
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $265,561 - $344,394	5,536 Added 9.69%	62,669 $3.77 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $607,432 - $681,472	11,117 Added 24.16%	57,133 $3.2 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $1.35 Million - $1.59 Million	22,746 Added 97.75%	46,016 $2.79 Million
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $827,848 - $1.1 Million	-13,958 Reduced 37.49%	23,270 $1.63 Million
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $1.12 Million - $1.47 Million	-22,172 Reduced 37.33%	37,228 $2.23 Million
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $339,571 - $411,642	6,534 Added 12.36%	59,400 $3.57 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $552,120 - $940,577	17,926 Added 51.31%	52,866 $2.77 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $680,066 - $1.21 Million	-23,946 Reduced 40.67%	34,940 $1.17 Million
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $729,322 - $940,627	20,086 Added 51.77%	58,886 $2.67 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $623,265 - $786,335	-17,478 Reduced 31.06%	38,800 $1.48 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $329,934 - $432,785	9,022 Added 19.09%	56,278 $2.45 Million
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $1.11 Million - $1.29 Million	30,527 Added 182.48%	47,256 $1.8 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $567,227 - $716,208	13,731 Added 458.01%	16,729 $720,000
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $120,460 - $190,684	-3,667 Reduced 55.02%	2,998 $147,000
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $174,240 - $252,172	6,336 Added 1925.84%	6,665 $214,000
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $129,033 - $199,490	-4,304 Reduced 92.9%	329 $10,000
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $67,936 - $100,144	2,133 Added 85.32%	4,633 $211,000
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $89,250 - $98,750	2,500	2,500 $94,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Pacira Bio Sciences, Inc. Transaction History